COVID-19 Archives | Page 74 of 202 | Be Korea-savvy
Daily Infections, Serious Cases at Record High amid Growing Omicron Woes

Daily Infections, Serious Cases at Record High amid Growing Omicron Woes

SEOUL, Dec. 2 (Korea Bizwire) — South Korea’s daily coronavirus cases and the number of critically ill patients hit record highs Thursday amid deepening concerns over the potentially more transmissible omicron variant following its first confirmed infections a day earlier. South Korea reported 5,266 new COVID-19 cases, including 5,242 local infections, raising the total caseload [...]

Gatherings Canceled, Remote Work Opted for Again over Omicron Variant Anxieties

Gatherings Canceled, Remote Work Opted for Again over Omicron Variant Anxieties

SEOUL, Dec. 2 (Korea Bizwire) — A growing number of people across Seoul have been choosing to cancel or put off year-end gatherings and opting to work from home amid a surge in new virus patients and the confirmation of the country’s first omicron variant cases, according to anecdotes Thursday. South Korea confirmed five omicron [...]

Omicron Woes Dash Growing Hopes for Overseas Travel

Omicron Woes Dash Growing Hopes for Overseas Travel

SEOUL, Dec. 2 (Korea Bizwire) — Fears over the omicron coronavirus variant are dashing hopes for the resumption of overseas travel, forcing many to cancel or postpone travel plans, including honeymoons, only a month after the country’s “living with COVID-19″ policy revived expectations for a return to normal. South Korea confirmed five omicron infections a [...]

S. Korea Brings Back Airport Screening, Quarantine Measures amid 1st Omicron Case Confirmations

S. Korea Brings Back Airport Screening, Quarantine Measures amid 1st Omicron Case Confirmations

SEOUL, Dec. 1 (Korea Bizwire) — South Korea decided Wednesday to reimpose strict passenger screening at airports, mandatory quarantine and other measures to prevent the spread of the emerging omicron variant of COVID-19 after reporting the first such cases in the country. A married couple in their 40s, living in Incheon, west of Seoul, and [...]

Daily Virus Cases Top 5,000, 1st Confirmed Omicron Cases Compound Woes

Daily Virus Cases Top 5,000, 1st Confirmed Omicron Cases Compound Woes

SEOUL, Dec. 1 (Korea Bizwire) — The state of urgency surrounding the pandemic in South Korea escalated to a new high Wednesday, as new coronavirus cases topped 5,000 for the first time while health authorities confirmed the first omicron variant infections in the country. The country reported 5,123 new COVID-19 cases, including 5,075 local infections, [...]

Daily Virus Cases Below 4,000 for 3rd Day; Critical Cases Hit Record High amid New Variant Woes

Daily Virus Cases Below 4,000 for 3rd Day; Critical Cases Hit Record High amid New Variant Woes

SEOUL, Nov. 30 (Korea Bizwire) — South Korea’s new coronavirus cases stayed below 4,000 for the third straight day Tuesday, but the number of critically ill patients hit a fresh high amid concerns over the global spread of the new virus variant. The country reported 3,032 new COVID-19 cases, including 3,003 local infections, raising the [...]

Daily Virus Cases Below 4,000 for 2nd Day; Further Easing of Virus Curbs Halted

Daily Virus Cases Below 4,000 for 2nd Day; Further Easing of Virus Curbs Halted

SEOUL, Nov. 29 (Korea Bizwire) — South Korea’s new coronavirus cases stayed below 4,000 for the second straight day Monday due largely to fewer tests, but the continued spike in infections and high number of critically ill patients prompted the country to halt further easing of distancing rules. The country reported 3,309 new COVID-19 cases, [...]

Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, Omicron, Are Associated with Escape from ADG20 Neutralization In Vitro

Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, Omicron, Are Associated with Escape from ADG20 Neutralization In Vitro

WALTHAM, Mass., Nov. 29 (Korea Bizwire) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today provided information related to the potential of its lead SARS-CoV-2 antibody, ADG20, to address the Omicron SARS-CoV-2 variant, and other known variants [...]